malonamide has been researched along with thienopyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaulieu, C; Beaulieu, N; Bernstein, N; Besterman, JM; Claridge, S; Déziel, R; Dupont, I; Gaudette, F; Granger, MC; Isakovic, L; Macleod, AR; Mannion, M; Nguyen, H; Raeppel, F; Raeppel, S; Saavedra, O; Vaisburg, A; Wang, J; Zhan, L; Zhou, N | 1 |
1 other study(ies) available for malonamide and thienopyridine
Article | Year |
---|---|
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Malonates; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Vascular Endothelial Growth Factor Receptor-2 | 2009 |